Arkolith/Insider Trading/APYX/Form 4

Goodwin Charles D. II

Chief Executive Officer, DirectorApyx Medical Corp (APYX) · full profile →Form 4 · filed Aug 31, 2022
Net Buying
Open-Market Buys
$70K
Open-Market Sells
$0
Net Open-Market Flow
$70K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 29, 2022Buy(P)10K$5.97$58K40K
Aug 29, 2022Buy(P)2K$5.93$12K30K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000719135-22-000084) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML